Aim: The objective of this study is to evaluate an animal model, herein called the Tunac Arterial Plaque (TAP) mouse as a model for reduced left ventricle ejection fraction (LVEF). Traditional mouse models involve genetically modified or surgically altered animals, whereas the TAP model is a wild mouse (C57Bl/6 strain) fed with a high fat diet and treated with an environmental chemical pollutant 3,3',4,4'-Tetrachlorobiphenyl (PCB) to mimic human lifestyle. Thus, the LVEF volume of treated and untreated mice will be measured per MRI, as well as an assessment for the presence of arterial plaque. Methods and results: Ten-week-old male C57/Bl6 mice were fed with either normal or high fat diet, acclimated for 1 week and then PCB was administered by gavage. Magnetic resonance imaging (MRI) was performed using a 7-Tesla Varian magnet. Briefly, the heart was aligned to the proper orientation, then an intragate scan was carried out for a CINE presentation (motion sensitive MRI in which a series of static images are obtained at various stages of the cardiac cycle and then played back as a movie). A black blood method was used that caused the blood to appear darker than the adjacent tissue and a CINE sequence to sort images, from which another program a (Medviso Segment) calculated percent ejection fraction (EF), heart rate (HR) and respiratory rate (RR). For the aorta and carotid artery imaging, cross-sectional images of the aortic arch were obtained, which produced multiple contrast weightings. Mice fed with normal diet showed normal ejection fraction volume (75.1%). The high fat diet alone without PCB also effectively reduced EF% (67.7%), and the lowest reduction in EF were for mice fed with high fat and PCB (57.2%). In the high fat-PCB-treated group, there was a gradual reduction in % EF starting at 2 weeks with 65.2% EF and 52.5% at the 8-wk time point. MRI scan of the aortal arch showed plaques in mice fed with high fat diet and PCB treatment. Conclusions: First to demonstrate LVEF per cine MRI in a wild non-surgical or non-genetically modified mouse model. Plaque formation in aortal arch was confirmed by MRI.
Published in | Cardiology and Cardiovascular Research (Volume 5, Issue 3) |
DOI | 10.11648/j.ccr.20210503.13 |
Page(s) | 141-146 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Cardiac, Heart Failure, MRI, Ejection Fraction, Plaque, Mice
[1] | Ponikowski P, Anker S, AlHabib K, Cowie M, Force T, Hu S, et al. (2014). Heart failure: Preventing disease and death worldwide ESC Heart Fail, 1: 4-25. |
[2] | Virani S, Alonso A, Benjamin E, Marcio S, Bittencourt M, Callaway C, et al. (2020). Heart disease and stroke statistics—2020 update: A report from the american heart association. Circulation, 141: e139-e596. |
[3] | Borlaug B. (2014). The pathophysiology of heart failure with preserved ejection fraction. Nat. Rev. Cardiol, 11: 507-515. |
[4] | Pfeffer M, Shah A, Borlaug B. (2018). Heart failure with preserved ejection fraction in perspective. Circ Res, 124: 1598-1617. |
[5] | Shah S, Kitzman D, Borlaug B, van Heerebeek L, Zile M, Kass D, et al. (2016). Phenotype-specific treatment of heart failure with preserved ejection fraction. Circulation, 134: 73-90. |
[6] | Oeing C, Tschöpe C, Pieske B. (2016). The new ESC guidelines for acute and chronic heart failure 2016. Herz, 41: 655-663. |
[7] | Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A, et al. (2016). 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC). Eur Heart J, 37: 2129–2200. |
[8] | Hsu J, Ziaeian B, Fonarow G. (2017). Heart failure with mid-range (borderline) ejection fraction: Clinical implications and future directions. JACC Heart Fail, 5: 763-771. |
[9] | Tibrewala A, Yancy C. (2019). Heart failure with preserved ejection fraction in women. Heart Fail Clin, 15: 9-18. |
[10] | Deng Y, Xie M, Li Q, Xu X, Ou W, Zhang Y, et al. (2021). Targeting mitochondria-inflammation circuit by β-hydroxybutyrate mitigates HFpEF. Circ Res, 128: 232-245. |
[11] | Roh J, Houstis N, Rosenzweig A. (2017). Why don't we have proven treatments for HFpEF? Circ Res, 120: 1243-1245. |
[12] | Yoon S, Eom G. (2019). Heart failure with preserved ejection fraction: Present status and future directions. Exp Mol Med, 51: 1-9. |
[13] | Sam F, Xie Z, Ooi H, Kerstetter D, Colucci W, Singh M, et al. (2004). Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. Am J Hypertens, 17: 188-193. |
[14] | Tsukamoto Y, Mano T, Sakata Y, Ohtani T, Takeda Y, Tamaki S, et al. (2013). A novel heart failure mice model of hypertensive heart disease by angiotensin ii infusion, nephrectomy, and salt loading. Am J Physiol Heart Circ Physiol, 305: H1658-1667. |
[15] | Valero-Muñoz M, Backman W, Sam F. (2017). Murine models of heart failure with preserved ejection fraction: A "fishing expedition". JACC Basic Transl Sci, 2: 770-789. |
[16] | Schiattarella G, Altamirano F, Tong D, French K, Villalobos E, Kim S, et al. (2019). Nitrosative stress drives heart failure with preserved ejection fraction. Nature, 568: 351-356. |
[17] | Lüscher T. (2016). Heart failure and left ventricular remodelling in HFrEF and HFpEF. Eur Heart J, 37: 423-424. |
[18] | Wooley P, Tunac J. (2017). A novel model of atherosclerosis in mice J Clin Exp Cardiolog, 8: 1. |
[19] | Xie B, Tian Y, Zhang J, Zhao S, Yang M, Guo F, et al. (2012). Evaluation of left and right ventricular ejection fraction and volumes from gated blood-pool SPECT in patients with dilated cardiomyopathy: Comparison with cardiac MRI. J Nucl Med, 53: 584-591. |
[20] | Higuchi T, Nekolla S, Jankaukas A, Weber A, Huisman M, Reder S, et al. (2007). Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI. J Nucl Med, 48: 288-294. |
[21] | Kreissl M, Wu H, Stout D, Ladno W, Schindler T, Zhang X, et al. (2006). Noninvasive measurement of cardiovascular function in mice with high-temporal-resolution small-animal PET. J Nucl Med, 47: 974-980. |
[22] | Stegger L, Heijman E, Schafers K, Nicolay K, Schafers M, Strijkers G. (2009). Quantification of left ventricular volumes and ejection fraction in mice using PET, compared with MRI. J Nucl Med, 50: 132-138. |
[23] | Brunner S, Todica A, Böning G, Nekolla S, Wildgruber M, Lehner S, et al. (2012). Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 f] fdg-PET: Comparison with cardiac MRI and monitoring erythropoietin therapy. EJNMMI Res, 2: 43. |
[24] | O'Grady Milbrath M, Wenger Y, Chang C, Emond C, Garabrant D, Gillespie B, et al. (2009). Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding. Environ Health Perspect, 117: 417-425. |
[25] | Faroon O, Ruiz P. (2016). Polychlorinated biphenyls: New evidence from the last decade. Toxicol Ind Health, 32: 1825-1847. |
[26] | Hue O, Marcotte J, Berrigan F, Simoneau M, Doré J, Marceau P, et al. (2007) Plasma concentration of organochlorine compounds is associated with age and not obesity. Chemosphere, 67: 1463-1467. |
[27] | van Empel V, Bertrand A, Hofstra L, Crijns H, Doevendans P, De Windt L. (2005). Myocyte apoptosis in heart failure. Cardiovasc Res, 67: 21-29. |
[28] | Trogan E, Fayad Z, Itskovich V, Aguinaldo J, Mani V, Fallon J, et al. (2004). Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. Arterioscler Thromb Vasc Biol, 24: 1714-1719. |
APA Style
Josefino Tunac, Frederick Valeriote, Joseph Media, Robert Knight. (2021). Novel Animal Model for Ventricular Ejection Fraction Measured by MRI. Cardiology and Cardiovascular Research, 5(3), 141-146. https://doi.org/10.11648/j.ccr.20210503.13
ACS Style
Josefino Tunac; Frederick Valeriote; Joseph Media; Robert Knight. Novel Animal Model for Ventricular Ejection Fraction Measured by MRI. Cardiol. Cardiovasc. Res. 2021, 5(3), 141-146. doi: 10.11648/j.ccr.20210503.13
AMA Style
Josefino Tunac, Frederick Valeriote, Joseph Media, Robert Knight. Novel Animal Model for Ventricular Ejection Fraction Measured by MRI. Cardiol Cardiovasc Res. 2021;5(3):141-146. doi: 10.11648/j.ccr.20210503.13
@article{10.11648/j.ccr.20210503.13, author = {Josefino Tunac and Frederick Valeriote and Joseph Media and Robert Knight}, title = {Novel Animal Model for Ventricular Ejection Fraction Measured by MRI}, journal = {Cardiology and Cardiovascular Research}, volume = {5}, number = {3}, pages = {141-146}, doi = {10.11648/j.ccr.20210503.13}, url = {https://doi.org/10.11648/j.ccr.20210503.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20210503.13}, abstract = {Aim: The objective of this study is to evaluate an animal model, herein called the Tunac Arterial Plaque (TAP) mouse as a model for reduced left ventricle ejection fraction (LVEF). Traditional mouse models involve genetically modified or surgically altered animals, whereas the TAP model is a wild mouse (C57Bl/6 strain) fed with a high fat diet and treated with an environmental chemical pollutant 3,3',4,4'-Tetrachlorobiphenyl (PCB) to mimic human lifestyle. Thus, the LVEF volume of treated and untreated mice will be measured per MRI, as well as an assessment for the presence of arterial plaque. Methods and results: Ten-week-old male C57/Bl6 mice were fed with either normal or high fat diet, acclimated for 1 week and then PCB was administered by gavage. Magnetic resonance imaging (MRI) was performed using a 7-Tesla Varian magnet. Briefly, the heart was aligned to the proper orientation, then an intragate scan was carried out for a CINE presentation (motion sensitive MRI in which a series of static images are obtained at various stages of the cardiac cycle and then played back as a movie). A black blood method was used that caused the blood to appear darker than the adjacent tissue and a CINE sequence to sort images, from which another program a (Medviso Segment) calculated percent ejection fraction (EF), heart rate (HR) and respiratory rate (RR). For the aorta and carotid artery imaging, cross-sectional images of the aortic arch were obtained, which produced multiple contrast weightings. Mice fed with normal diet showed normal ejection fraction volume (75.1%). The high fat diet alone without PCB also effectively reduced EF% (67.7%), and the lowest reduction in EF were for mice fed with high fat and PCB (57.2%). In the high fat-PCB-treated group, there was a gradual reduction in % EF starting at 2 weeks with 65.2% EF and 52.5% at the 8-wk time point. MRI scan of the aortal arch showed plaques in mice fed with high fat diet and PCB treatment. Conclusions: First to demonstrate LVEF per cine MRI in a wild non-surgical or non-genetically modified mouse model. Plaque formation in aortal arch was confirmed by MRI.}, year = {2021} }
TY - JOUR T1 - Novel Animal Model for Ventricular Ejection Fraction Measured by MRI AU - Josefino Tunac AU - Frederick Valeriote AU - Joseph Media AU - Robert Knight Y1 - 2021/09/11 PY - 2021 N1 - https://doi.org/10.11648/j.ccr.20210503.13 DO - 10.11648/j.ccr.20210503.13 T2 - Cardiology and Cardiovascular Research JF - Cardiology and Cardiovascular Research JO - Cardiology and Cardiovascular Research SP - 141 EP - 146 PB - Science Publishing Group SN - 2578-8914 UR - https://doi.org/10.11648/j.ccr.20210503.13 AB - Aim: The objective of this study is to evaluate an animal model, herein called the Tunac Arterial Plaque (TAP) mouse as a model for reduced left ventricle ejection fraction (LVEF). Traditional mouse models involve genetically modified or surgically altered animals, whereas the TAP model is a wild mouse (C57Bl/6 strain) fed with a high fat diet and treated with an environmental chemical pollutant 3,3',4,4'-Tetrachlorobiphenyl (PCB) to mimic human lifestyle. Thus, the LVEF volume of treated and untreated mice will be measured per MRI, as well as an assessment for the presence of arterial plaque. Methods and results: Ten-week-old male C57/Bl6 mice were fed with either normal or high fat diet, acclimated for 1 week and then PCB was administered by gavage. Magnetic resonance imaging (MRI) was performed using a 7-Tesla Varian magnet. Briefly, the heart was aligned to the proper orientation, then an intragate scan was carried out for a CINE presentation (motion sensitive MRI in which a series of static images are obtained at various stages of the cardiac cycle and then played back as a movie). A black blood method was used that caused the blood to appear darker than the adjacent tissue and a CINE sequence to sort images, from which another program a (Medviso Segment) calculated percent ejection fraction (EF), heart rate (HR) and respiratory rate (RR). For the aorta and carotid artery imaging, cross-sectional images of the aortic arch were obtained, which produced multiple contrast weightings. Mice fed with normal diet showed normal ejection fraction volume (75.1%). The high fat diet alone without PCB also effectively reduced EF% (67.7%), and the lowest reduction in EF were for mice fed with high fat and PCB (57.2%). In the high fat-PCB-treated group, there was a gradual reduction in % EF starting at 2 weeks with 65.2% EF and 52.5% at the 8-wk time point. MRI scan of the aortal arch showed plaques in mice fed with high fat diet and PCB treatment. Conclusions: First to demonstrate LVEF per cine MRI in a wild non-surgical or non-genetically modified mouse model. Plaque formation in aortal arch was confirmed by MRI. VL - 5 IS - 3 ER -